Maravai LifeSciences Holdings (STU:MAR) FCF Margin % : -22.02% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Maravai LifeSciences Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Maravai LifeSciences Holdings's Free Cash Flow for the three months ended in Mar. 2024 was €-13.0 Mil. Maravai LifeSciences Holdings's Revenue for the three months ended in Mar. 2024 was €59.0 Mil. Therefore, Maravai LifeSciences Holdings's FCF Margin % for the quarter that ended in Mar. 2024 was -22.02%.

As of today, Maravai LifeSciences Holdings's current FCF Yield % is -2.68%.

The historical rank and industry rank for Maravai LifeSciences Holdings's FCF Margin % or its related term are showing as below:

STU:MAR' s FCF Margin % Range Over the Past 10 Years
Min: -11.15 Med: 32.63 Max: 58.76
Current: -11.15

During the past 6 years, the highest FCF Margin % of Maravai LifeSciences Holdings was 58.76%. The lowest was -11.15%. And the median was 32.63%.

STU:MAR's FCF Margin % is ranked better than
72.51% of 1044 companies
in the Biotechnology industry
Industry Median: -139.2 vs STU:MAR: -11.15

Maravai LifeSciences Holdings FCF Margin % Historical Data

The historical data trend for Maravai LifeSciences Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maravai LifeSciences Holdings FCF Margin % Chart

Maravai LifeSciences Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

4.87

44.63

44.26

58.76

21.00

Maravai LifeSciences Holdings Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															97.70	-8.51	-2.48	-12.15	-22.02

Competitive Comparison of Maravai LifeSciences Holdings's FCF Margin %

For the Biotechnology subindustry, Maravai LifeSciences Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maravai LifeSciences Holdings's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Maravai LifeSciences Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Maravai LifeSciences Holdings's FCF Margin % falls into.

Maravai LifeSciences Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Maravai LifeSciences Holdings's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	55.635	/	264.963
	=	21.00 %

Maravai LifeSciences Holdings's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-13.002	/	59.045
	=	-22.02 %

Maravai LifeSciences Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Maravai LifeSciences Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Maravai LifeSciences Holdings (STU:MAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maravai LifeSciences Holdings Inc (STU:MAR) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

MRVI:USA MRVI:Mexico

Address

10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121

Website

https://www.maravai.com

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.